We & Win Diversification Co., Ltd.

Taipei Exchange 4113.TWO

We & Win Diversification Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 10.99

We & Win Diversification Co., Ltd. Price to Sales Ratio (P/S) is 10.99 on January 14, 2025, a -51.54% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • We & Win Diversification Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 23.22 on August 01, 2024, which is 111.23% above the current Price to Sales Ratio (P/S).
  • We & Win Diversification Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 10.99 on January 14, 2025, which is 0.00% below the current Price to Sales Ratio (P/S).
  • We & Win Diversification Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 15.03.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Taipei Exchange: 4113.TWO

We & Win Diversification Co., Ltd.

CEO Mr. Yung-Yi Su
IPO Date Dec. 31, 2007
Location
Headquarters No. 185, Fuguo Road
Employees 35
Sector Consumer Staples
Industries
Retail & Wholesale Oil & Gas
Description

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email